Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Appointed CFO Director departure Inv. presentation
|
Targeted Medical Pharma, Inc. (TRGM)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
05/17/2019 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
01/22/2019 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
12/12/2017 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
10/01/2015 |
8-K
| Quarterly results |
03/03/2015 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
02/27/2015 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
02/06/2015 |
8-K
| Resignation/termination of a director |
01/20/2015 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits |
01/12/2015 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
01/07/2015 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
01/06/2015 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
06/11/2014 |
8-K
| Submission of Matters to a Vote of Security Holders |
05/20/2014 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
04/01/2014 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
03/11/2014 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs:
|
"Healthcare Executive Dr. Thomas Wenkart Joins Targeted Medical Pharma’ s Board of Directors Los Angeles, March 5, 2014 –Targeted Medical Pharma, Inc. today announced that Dr. Thomas Wenkart, Chief Executive and Chairman at Macquarie Health Corporation, has joined the company’ s board of directors. A nationally respected expert in healthcare, medical and hospital administration in Australia, Dr. Wenkart established Macquarie Health Corporation in Sydney, Australia in 1976. His organization owns and operates eleven private hospitals in Australia, and is one of the nation’ s leading providers of healthcare services. Dr. Wenkart is a graduate of the Sydney University School of Medicine. In 1976, he established the Health Care Research Institute and the Wenkart Foundation which supports the Art...",
"Dr. Tom Wenkart - Bio" |
|
01/02/2014 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
10/07/2013 |
8-K
| Form 8-K - Current report |
09/09/2013 |
8-K
| Form 8-K - Current report |
08/21/2013 |
8-K
| Appointed CFO
Docs:
|
"Employment Agreement, effective as of August 19, 2013, by and between the Company and William B. Horne",
"Targeted Medical Pharma Selects William B. Horne as Chief Financial officer Los Angeles, August 21, 2013, Targeted Medical Pharma, Inc. , a biotechnology company that develops and distributes prescription medical foods, convenience kits and generic pharmaceuticals to physicians and pharmacies, today announced the appointment of William B. Horne as the company’ s Chief Financial Officer. He will oversee all aspects of the company’ s fiscal operations and financial reporting.",
"Targeted Medical Pharma Selects William B. Horne as Chief Financial officer Los Angeles, August 21, 2013, Targeted Medical Pharma, Inc. , a biotechnology company that develops and distributes prescription medical foods, convenience kits and generic pharmaceuticals to physicians and pharmacies, today announced the appointment of William B. Horne as the company’ s Chief Financial Officer. He will oversee all aspects of the company’ s fiscal operations and financial reporting." |
|
08/01/2013 |
8-K
| Form 8-K - Current report |
07/03/2013 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
06/12/2013 |
8-K
| Form 8-K - Current report |
05/20/2013 |
8-K
| Resignation/termination of a director |
04/23/2013 |
8-K
| Investor presentation |
04/18/2013 |
8-K
| Other Events, Financial Statements and Exhibits |
03/21/2013 |
8-K
| Form 8-K - Current report |
02/13/2013 |
8-K
| Other Events, Financial Statements and Exhibits |
01/07/2013 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits |
11/29/2012 |
8-K
| Form 8-K - Current report |
11/07/2012 |
8-K
| Form 8-K - Current report |
10/05/2012 |
8-K
| Form 8-K - Current report |
08/07/2012 |
8-K
| Form 8-K - Current report |
07/18/2012 |
8-K
| Form 8-K - Current report |
06/15/2012 |
8-K
| Form 8-K - Current report |
|
|
|